Five Stock Picks From Hedge Fund Sophrosyne Capital
Sophrosyne Capital is a multi strategy hedge fund founded in 2005. The firm has about $200 million in assets under management and is based in New York, NY.
Hedge Fund - Sophrosyne Capital
Get Email AlertsBenjamin J Taylor Bio, Returns, AUM, Net Worth
Manager biography is currently missing.
Fund Profile
Filing Period:
| Fund Name: | Sophrosyne Capital |
| Manager | Benjamin J Taylor |
| Portfolio Value | $0 |
| Change This QTR | 0.00% |
News, Interviews and Investor Letters
Post Holdings Inc (POST), Nordion Inc(USA) (NDZ), Eastern Virginia Bankshares, Inc. (EVBS), Aspen Group Inc (ASPU) Witnessing Hedge Fund Activity
As we continue to track hedge funds’ SEC filings, we came across a few interesting transactions, into which we will look in this article.
3 Recent Moves by Benjamin Taylor’s Sophrosyne Capital
Benjamin Taylor’s Sophrosyne Capital dumped its shares in Ventrus Biosciences Inc (NASDAQ:VTUS). The fund reported ownership of 0.22 million shares of the firm in the last reported quarter of 2013.
Benjamin Taylor, Sophrosyne Capital Own 4.8% of S&W Seed
Benjamin Taylor, Sophrosyne Capital: S&W Seed Company (NASDAQ:SANW) recently was slightly reduced in the equity portfolio of Benjamin J Taylor's Sophrosyne Capital.
CardioNet/BioTelemetry Cut By Benjamin J. Taylor's Hedge Fund
CardioNet/BioTelemetry: CardioNet, Inc. is yet another company that has been recently downsized in the equity portfolio of a hedge fund.
